NCT06293521 Clinical and Radiographic Success Rate of Pulpotomy Versus Pulpectomy for Management of Primary Teeth With Deep Caries
| NCT ID | NCT06293521 |
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Cairo University |
| Condition | Deep Caries |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 40 participants in total. It began in 2026-01-01 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This trial aims to compare treatment outcomes between Pulpotomy and Pulpectomy in treating vital primary teeth diagnosed with deep caries with symptoms of irreversible pulpits
Eligibility Criteria
Inclusion Criteria: 1. Aged 4 to 6 years , in good general health 2. The parents provided written informed consent. 3. Clinical characteristics, defined as spontaneous pain and the presence of a deep carious lesion with pulp exposure and bleeding that did not halt within five minutes following removal of the coronal pulp tissue. 4. Restorable teeth. Exclusion Criteria: 1. Physical or mental disability. 2. Unable to attend follow-up visits. 3. Previously accessed teeth. 4. Swelling, tenderness to percussion or palpation, or pathological mobility. 5. Pre-operative radiographic pathology such as resorption (internal or external), per-radicular or furcation radiolucency.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06293521 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 6 Years, studying Deep Caries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06293521 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT06293521 currently recruiting?
Yes, NCT06293521 is actively recruiting participants. Contact the research team at Nadamostafa@dentistry.cu.edu.eg for enrollment information.
Where is the NCT06293521 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06293521 clinical trial?
NCT06293521 is sponsored by Cairo University. The trial plans to enroll 40 participants.